ROSUVASTATIN CALCIUM | A079145 | APOTEX INC
Total Spending
$604.4M
Total Claims
25,854,209
Beneficiaries
6,945,233
Avg Cost/Unit
$0.31
Spending Trend
Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.
39 active API suppliers hold Drug Master Files for this ingredient.
Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.
| Date | Submission | Document |
|---|---|---|
| Jul 20, 2016 | ORIG -1 | View Letter (PDF) |
Source: Drugs@FDA application documents.
No patent or exclusivity listings for this strength.